Table 1.
Variables | RVO (n = 57) | non-RVO (n = 125) | P-value |
Age, ya | 76.8 (9.4) | 75.6 (8.6) | .783∗ |
Sex: Maleb | 23 (40.4) | 43 (34.4) | .439∗ |
HTN, mm Hg | |||
SBPa | 137.1 (17.7) | 125.9 (13.2) | <.001∗ |
DBPa | 72.7 (11.8) | 65.6 (8.0) | <.001∗ |
120> and 80>b | 8 (14.0) | 38 (30.4) | |
120 ≤ SBP < 140 or 80 ≤ DBP < 90b | 25 (43.9) | 62 (49.6) | <.001∗∗ |
140 ≤ SBP < 160 or 90 ≤ DBP < 100b | 18 (31.6) | 25 (20.0) | |
SBP ≥ 160 or DBP ≥ 100b | 6 (10.5) | 0 | |
TC, mg/dLa | 203.4 (33.5) | 203.8 (35.4) | .468∗ |
LDL-C, mg/dLa | 119.6 (29.9) | 115.5 (27.3) | .819∗ |
HDL-C, mg/dLa | 55.0 (15.2) | 59.1 (14.0) | .039∗ |
Non-HDL-C, mg/dLa | 148.4 (32.4) | 144.7 (31.1) | .135∗ |
BMI, kg/m2 a | 22.5 (3.5) | 23.0 (3.6) | .180∗ |
eGFR (mL/min/1.73 m2)a | 67.6 (23.7) | 76.9 (22.8) | .006∗ |
DMb | 16 (28.1) | 26 (20.8) | .280∗∗ |
Alcohol intakeb | 12 (21.1) | 41 (32.8) | .106∗∗ |
Smokingb | 12 (21.1) | 31 (24.8) | .110∗∗ |
Medication | |||
Anticoagulantb | 5 (8.8) | 6 (4.8) | .297∗∗ |
Antiplatelet drugb | 12 (21.1) | 25 (20.0) | .870∗∗ |
Othersb | 5 (8.8) | 5 (4.0) | .190∗∗ |
Anti-VEGFc: number of times 0b | 12 (21.1) | 120 (96) | |
1b | 12 (21.1) | 0 | <.001∗∗ |
2b | 5 (8.8) | 1 (0.8) | |
≥3b | 28 (49.1) | 4 (3.2) |